OralAcute bacterial exacerbation of chronic bronchitis, Ear, nose and/or throat infections, Gonococcal urethritis in men, Lower respiratory tract infections, Otitis media, Pharyngotonsillitis, Pneumonia, Sinusitis, Tracheobronchitis, Urinary tract infectionsAdult: 500 mg bid.
|
Known hypersensitivity to cephalosporins.
|
Hypersensitivity to penicillins. Renal insufficiency; lactation.
|
Diarrhoea, nausea, vomiting, hypersensitivity reactions.
|
Description: Mechanism of Action: Cefetamet is a 3rd generation cephalosporin. It inhibits the final transpeptidation step of peptidoglycan synthesis in the bacterial cell wall by binding to one or more of the penicillin-binding proteins (PBPs).
|
|
|
Disclaimer: This information is independently developed by MIMS based on Cefetamet from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2025 MIMS. All rights reserved. Powered by MIMS.com